ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹104 Cr | ₹11 Cr | ₹-2.34 Cr | ₹14 Cr | ₹-30 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ERIS LIFESCIENCES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹-2.34 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹-30 Cr |
How is Net Cash Inflow / Outflow of ERIS LIFESCIENCES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 828.56 | |
| Mar2024 | ₹11 Cr | Positive | |
| Mar2023 | ₹-2.34 Cr | Negative | |
| Mar2022 | ₹14 Cr | Positive | |
| Mar2021 | ₹-30 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹20,108.1 Cr | 1% | 6.1% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 1% |
6.1% |
-16.3% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses